SCHEMBL6718288

SCHEMBL6718288

Cc1cccc(-c2noc(CF)c2-c2ccc(S(C)(=O)=O)c(F)c2)c1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.47
ALDH1A1 P00352 1/20 0.37
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LOX P28300 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
PTGS1 P23219 2/20 0.34
HTR7 P34969 1/20 0.34
PIK3CD O00329 2/20 0.34
PIK3CA P42336 2/20 0.34
PIK3CB P42338 2/20 0.34
PIK3CG P48736 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PDE3A Q14432 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6725376 0.91 PTGS2 (0.46) PTGS2ALDH1A1NPC1TP53RAB9A
SCHEMBL6720865 0.91 PTGS2 (0.54) PTGS2ALDH1A1NPC1TP53RAB9A
SCHEMBL6730006 0.90 PTGS2 (0.47) PTGS2ALDH1A1PTGS1
SCHEMBL6730253 0.90 PTGS2 (0.44) PTGS2ALDH1A1NPC1PTGS1PIK3CD
SCHEMBL6726190 0.89 PTGS2 (0.47) PTGS2ALDH1A1PTGS1PIK3CDPIK3CA
SCHEMBL6721862 0.89 PTGS2 (0.59) PTGS2ALDH1A1PTGS1PDE3A
SCHEMBL6722902 0.88 PTGS2 (0.46) PTGS2ALDH1A1PTGS1PIK3CDPIK3CA
SCHEMBL6721984 0.88 PTGS2 (0.46) PTGS2ALDH1A1RAB9APTGS1HTR7
SCHEMBL6722942 0.88 PTGS2 (0.44) PTGS2ALDH1A1PIK3CDPIK3CAPIK3CB
SCHEMBL6721628 0.88 PTGS2 (0.46) PTGS2PTGS1PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-05-13 US disclosed
EP-1296971-A2 2-FLUOROBENZENESULFONYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2003-04-02 EP disclosed
US-20020183362-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2002-12-05 US disclosed
WO-2001081332-A2 2-FLUOROBENZENESULFONYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2001-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183362-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, FPR1, PTGES2 PTGS2 5/4885ALDH1A1 263/4885NPC1 3884/4885
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, PTGES2, FPR1 PTGS2 5/4885ALDH1A1 298/4885NPC1 3792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.